Glioblastoma, IDH-Wildtype — Trials

Glioblastoma, IDH-Wildtype — Trials · CancerIndex

Clinical trials

Registered studies

303 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 76
Recruiting: 42
Ph III recruiting: 3
Growth YoY: —
Industry share: 12%
Top sponsor: Mayo Clinic
Termination share: 43.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (64)

clinicaltrialsPublishedShowing 301–303 of 303 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00165477	Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme	completed	Phase 2	23	Dana-Farber Cancer InstituteOTHER	1	Mar 10, 2010	clinicaltrials
NCT00114309	131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma	unknown	Phase 2	66	TransMolecularINDUSTRY	1	Apr 3, 2009	clinicaltrials
NCT00365222